Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition

Ahmad Qawasmi1, Angeli Landeros-Weisenberger, James F Leckman

  • 1Yale Child Study Center, Yale University, New Haven, Connecticut 06520, USA.

Pediatrics
|May 30, 2012
PubMed

Insights

Long-chain polyunsaturated fatty acids (LCPUFAs) supplementation in infant formula does not significantly improve early cognitive development. Further research is needed to explore potential long-term neurodevelopmental benefits.

Area of Science:

  • Nutritional Neuroscience
  • Developmental Pediatrics
  • Evidence-Based Medicine

Background:

  • Infant formula often includes long-chain polyunsaturated fatty acids (LCPUFAs) based on the hypothesis that they enhance cognitive development.
  • Numerous randomized controlled trials (RCTs) have investigated the impact of LCPUFA supplementation on infant cognition.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the efficacy of LCPUFA supplementation in infant formula on early cognitive development.
  • To synthesize evidence from RCTs to determine the effect of LCPUFA on cognitive outcomes in infants.

Main Methods:

  • A systematic search of PubMed, PsychInfo, and Scopus was performed to identify relevant RCTs.
  • The meta-analysis included 12 trials with 1802 infants, focusing on cognitive outcomes measured by the Bayley Scales of Infant Development.
  • Secondary analyses explored the influence of LCPUFA dose, sample characteristics, and methodological quality.

Main Results:

  • The meta-analysis found no statistically significant effect of LCPUFA supplementation on infant cognitive development.
  • No significant heterogeneity or publication bias was detected among the included trials.
  • Subgroup analyses and meta-regression did not reveal significant effects of LCPUFA dose or infant prematurity status on cognitive outcomes.

Conclusions:

  • Current evidence indicates that LCPUFA supplementation of infant formula does not enhance early cognitive development.
  • Further investigation is warranted to assess potential benefits of LCPUFA for later cognitive milestones and other neurodevelopmental markers.
Abstract